InvestorsObserver
×
News Home

Will Catalyst Biosciences Inc (CBIO) Underperform the Rest of the Stocks in the Healthcare Sector?

Friday, March 24, 2023 02:51 PM | InvestorsObserver Analysts

Mentioned in this article

Will Catalyst Biosciences Inc (CBIO) Underperform the Rest of the Stocks in the Healthcare Sector?

A rating of 16 puts Catalyst Biosciences Inc (CBIO) near the top of the Healthcare sector according to InvestorsObserver. Catalyst Biosciences Inc's score of 16 means that it ranks higher than 16% of stocks in the sector. In addition, its overall score of 64 ranks it higher than 64% of all stocks.

Overall Score - 64
CBIO has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on CBIO!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Catalyst Biosciences Inc Stock Today?

Catalyst Biosciences Inc (CBIO) stock is lower by -3.93% while the S&P 500 has gained 0.41% as of 2:47 PM on Friday, Mar 24. CBIO is lower by -$0.01 from the previous closing price of $0.20 on volume of 164,538 shares. Over the past year the S&P 500 has fallen -12.28% while CBIO is lower by -72.46%. CBIO earned $0.38 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 0.51. Click Here to get the full Stock Report for Catalyst Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App